Wealth Preservation Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-39
Closed -$5.38K 1144
2025
Q4
$5.38K Hold
39
﹤0.01% 369
2025
Q3
$5K Sell
39
-8
-17% -$976 ﹤0.01% 361
2025
Q2
$5.69K Buy
+47
New +$5.3K ﹤0.01% 347

Other funds holding NVS

Wealth Preservation Advisors's NVS Position: Q1 2026 in Review

Wealth Preservation Advisors sold out of Novartis (NVS) in Q1 2026, closing a stake of 39 shares — an estimated $5.38K sold.

Wealth Preservation Advisors first reported a position in NVS in Q2 2025 and held it in 3 quarters. The position peaked at $5.69K in Q2 2025. 1,601 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Wealth Preservation Advisors reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • Wealth Preservation Advisors sold 39 Novartis shares in Q1 2026, an estimated $5.38K.
  • Wealth Preservation Advisors first reported a position in Novartis in Q2 2025 and held it in 3 quarters.
  • Wealth Preservation Advisors's Novartis position peaked at $5.69K in Q2 2025.
  • 1,601 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.